Jun 2026 (Q2 FY26) — Aug 6, 2026
Ouster Q2 FY26 — Record Revenue and Strong Rev8 Adoption
Read the full callOuster earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 54.6 | +55.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -36.7 | +39.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -18.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $29.58 on 17 Oct 2025 → $28.86. High $62.52 (30 Jun 2026), low $16.63 (30 Mar 2026).
Overview
Call summaries
Ouster Q2 FY26 — Record Revenue and Strong Rev8 Adoption
Read the full callEvery analysed call
Financials
Net profit, year on year: +12% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 28 | 30 | 33 | 35 | 40 | 62 | 49 | 55 |
| Operating profit | -28 | -26 | -24 | -27 | -24 | 1 | -19 | -20 |
| Operating margin | −98.0% | −85.1% | −73.0% | −76.5% | −61.4% | 1.4% | −39.5% | −36.7% |
| Other income | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Profit before tax | -26 | -23 | -22 | -24 | -22 | 4 | -17 | -18 |
| Tax rate | 0.1% | −1.4% | −0.9% | 14.9% | −0.3% | 9.4% | −3.3% | −0.7% |
| Net profit | -26 | -24 | -22 | -21 | -22 | 4 | -17 | -18 |
| EPS ($ per share) | -0.54 | — | -0.42 | -0.38 | -0.37 | — | -0.28 | -0.27 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -209 | -303 | -442 | -816 | -913 | -973 |
| Total liabilities | — | 83 | 47 | 85 | 151 | 95 | 88 |
| Fixed assets | — | 10 | 10 | 10 | 10 | 10 | 32 |
| Investments | — | — | — | 0 | 139 | 126 | 141 |
| Total assets | — | 46 | 308 | 256 | 331 | 276 | 350 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -40 | -42 | -71 | -111 | -138 | -34 | -40 |
| Cash from investing | -7 | -4 | -15 | -5 | 51 | 15 | -36 |
| Cash from financing | 51 | 40 | 258 | 56 | 16 | 15 | 98 |
| Net cash flow | 3 | -6 | 172 | -60 | -72 | -5 | 22 |
| Capital expenditure | -7 | -4 | -4 | -5 | -3 | -4 | -25 |
| Free cash flow | -48 | -46 | -75 | -116 | -141 | -37 | -65 |
105 filings between Nov 11, 2025 and Oct 5, 2026.
Purchases
$178.0K
3 purchases by 1 insider
Sales
$47.36M
68 sales by 9 insiders
94% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 2 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Frichtl Mark | — | $31.06M | Sep 14, 2026 |
| Gianella Kenneth P. | — | $4.46M | Sep 14, 2026 |
| SPENCER DARIEN | — | $4.15M | Sep 14, 2026 |
| Pacala Charles Angus | — | $3.38M | Sep 14, 2026 |
| Chung Megan | — | $1.62M | Sep 14, 2026 |
| Jacquemet Cyrille | — | $1.37M | Sep 14, 2026 |
| Heystee Susan | — | $615.8K | May 21, 2026 |
| SKAGGS STEPHEN A | — | $517.7K | Aug 6, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Heystee Susan Director | Award | 779 | $34.4K |
| Sep 14, 2026 | Pacala Charles Angus President and CEO | Sale 10b5-1 plan | 30,385 | $1.03M |
| Sep 14, 2026 | SPENCER DARIEN Chief Operating Officer | Sale 10b5-1 plan | 12,808 | $435.0K |
| Sep 14, 2026 | Gianella Kenneth P. Chief Financial Officer | Sale 10b5-1 plan | 15,686 | $532.7K |
| Sep 14, 2026 | Jacquemet Cyrille Chief Revenue Officer | Sale | 8,896 | $302.1K |
| Sep 14, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 18,778 | $637.7K |
| Sep 14, 2026 | Chung Megan General Counsel and Secretary | Sale 10b5-1 plan | 11,484 | $390.0K |
| Sep 9, 2026 | Chung Megan General Counsel and Secretary | Gift | 2,084 | $0 |
| Sep 2, 2026 | Frichtl Mark Chief Technology Officer | Gift | 38,745 | $0 |
| Aug 26, 2026 | Frichtl Mark Chief Technology Officer | Option exercise | 100,000 | $1.42M |
| Aug 18, 2026 | Gianella Kenneth P. Chief Financial Officer | Sale 10b5-1 plan | 8,201 | $380.6K |
| Aug 18, 2026 | Gianella Kenneth P. Chief Financial Officer | Sale 10b5-1 plan | 13,364 | $608.4K |
| Aug 18, 2026 | Gianella Kenneth P. Chief Financial Officer | Sale 10b5-1 plan | 17,927 | $800.4K |
| Aug 18, 2026 | Gianella Kenneth P. Chief Financial Officer | Sale 10b5-1 plan | 508 | $23.9K |
| Aug 6, 2026 | SKAGGS STEPHEN A Director | Sale 10b5-1 plan | 3,614 | $163.3K |
| Aug 5, 2026 | SKAGGS STEPHEN A Director | Sale 10b5-1 plan | 1,386 | $64.4K |
| Aug 4, 2026 | SPENCER DARIEN Chief Operating Officer | Sale 10b5-1 plan | 30,000 | $1.35M |
| Jul 6, 2026 | Heystee Susan Director | Award | 660 | $32.9K |
| Jun 22, 2026 | Tewksbury Ted L III Director | Sale 10b5-1 plan | 1,695 | $79.7K |
| Jun 17, 2026 | SKAGGS STEPHEN A Director | Award | 4,725 | $0 |
| Jun 17, 2026 | Eyler Phillip Director | Award | 4,725 | $0 |
| Jun 17, 2026 | MADDOCK ERNEST E Director | Award | 4,725 | $0 |
| Jun 17, 2026 | Tewksbury Ted L III Director | Award 10b5-1 plan | 4,725 | $0 |
| Jun 17, 2026 | Correia Christina Director | Award | 4,725 | $0 |
| Jun 17, 2026 | Heystee Susan Director | Award | 4,725 | $0 |
| Jun 12, 2026 | Pacala Charles Angus President and CEO | Sale 10b5-1 plan | 29,797 | $1.16M |
| Jun 12, 2026 | Chung Megan General Counsel and Secretary | Sale 10b5-1 plan | 11,261 | $437.2K |
| Jun 12, 2026 | Gianella Kenneth P. Chief Financial Officer | Sale 10b5-1 plan | 54,337 | $2.11M |
| Jun 12, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 18,414 | $714.9K |
| Jun 12, 2026 | Jacquemet Cyrille Chief Revenue Officer | Sale | 8,723 | $338.7K |
| Jun 12, 2026 | SPENCER DARIEN Chief Operating Officer | Sale 10b5-1 plan | 12,559 | $487.6K |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 45,000 | $1.98M |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 45,000 | $1.94M |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 48,191 | $2.02M |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 70,558 | $2.89M |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 76,582 | $3.06M |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 19,669 | $770.2K |
| May 26, 2026 | Jacquemet Cyrille Chief Revenue Officer | Sale 10b5-1 plan | 9,433 | $377.3K |
| May 26, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 3,742 | $168.4K |
| May 26, 2026 | SPENCER DARIEN Chief Operating Officer | Sale 10b5-1 plan | 30,001 | $1.35M |
| May 22, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 35,684 | $1.30M |
| May 22, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 40,000 | $1.49M |
| May 22, 2026 | Frichtl Mark Chief Technology Officer | Option exercise 10b5-1 plan | 50,063 | $711.9K |
| May 21, 2026 | Heystee Susan Director | Sale | 9,316 | $324.2K |
| May 15, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 4,316 | $155.4K |
| May 15, 2026 | Frichtl Mark Chief Technology Officer | Option exercise 10b5-1 plan | 4,316 | $61.4K |
| May 14, 2026 | Jacquemet Cyrille Chief Revenue Officer | Sale 10b5-1 plan | 10,000 | $350.0K |
| May 14, 2026 | Frichtl Mark Chief Technology Officer | Sale 10b5-1 plan | 40,000 | $1.40M |
| May 14, 2026 | Frichtl Mark Chief Technology Officer | Option exercise 10b5-1 plan | 40,000 | $568.8K |
| May 13, 2026 | Frichtl Mark Chief Technology Officer | Option exercise 10b5-1 plan | 31,434 | $67.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Ouster, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading